Lamotrigine
- Product NDC
- 10370-207
- 11-digit product format
- 103700207
- Labeler code
- 10370
- Product ID
- 10370-207_4e8e57a4-ecd3-4fce-943c-1ad74ea1ecc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamotrigine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Par Health USA, LLC
- Application
- ANDA201374
- Marketing category
- ANDA
- Marketing start
- 2026-01-02
- Substance
- LAMOTRIGINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201374-001 | LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-002 | LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-003 | LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-004 | LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-005 | LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-006 | LAMOTRIGINE | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201374-001 | AB |
| A201374-002 | AB |
| A201374-003 | AB |
| A201374-004 | AB |
| A201374-005 | AB |
| A201374-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A201374-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-006 | AB | 1 | 31067a03dcf5… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-005 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-006 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-005 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-006 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-004 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-005 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-006 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-004 | AB | 1 | 74a2ff9319b5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lamotrigine
- Brand name suffix
- Extended-Release
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LAMOTRIGINE | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U3H27498KS | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d5ec4d58-c669-4ab4-ba62-b71007536854 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 14a9502b-3d70-0496-a7e1-b16edaa005b8 | Product name | 5 | 20250423 |
| 16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0 | Product name | 7 | 20250401 |
| e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10370-207-11 | LamotrigineExtended-Release | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamotrigine Extended-Release | LAMOTRIGINE | Par Health USA, LLC | d5ec4d58-c669-4ab4-ba62-b71007536854 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 201374 ANDA201374 10370-207 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 850087 | lamoTRIgine 100 MG 24HR Extended Release Oral Tablet | PSN | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 900156 | lamoTRIgine 200 MG 24HR Extended Release Oral Tablet | PSN | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1146690 | lamoTRIgine 250 MG 24HR Extended Release Oral Tablet | PSN | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1098608 | lamoTRIgine 300 MG 24HR Extended Release Oral Tablet | PSN | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 850087 | 24 HR lamotrigine 100 MG Extended Release Oral Tablet | SCD | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 900156 | 24 HR lamotrigine 200 MG Extended Release Oral Tablet | SCD | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1146690 | 24 HR lamotrigine 250 MG Extended Release Oral Tablet | SCD | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1098608 | 24 HR lamotrigine 300 MG Extended Release Oral Tablet | SCD | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 850087 | lamotrigine 100 MG 24 HR Extended Release Oral Tablet | SY | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 900156 | lamotrigine 200 MG 24 HR Extended Release Oral Tablet | SY | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1146690 | lamotrigine 250 MG 24 HR Extended Release Oral Tablet | SY | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
| 1098608 | lamotrigine 300 MG 24 HR Extended Release Oral Tablet | SY | d5ec4d58-c669-4ab4-ba62-b71007536854 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 10370-207-11 | 10370020711 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10370-207-11) | 2026-01-02 | No | No | Current |